Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology.

MLA

Poudel, Yam B., et al. “Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With APD1 for Use in Immuno-Oncology.” ACS Medicinal Chemistry Letters, vol. 15, no. 2, Jan. 2024, pp. 181–88. EBSCOhost, https://doi.org/10.1021/acsmedchemlett.3c00455.

APA

Poudel, Y. B., He, L., Cox, M., Zhang, Q., Johnson, W. L., Cong, Q., Cheng, H., Chowdari, N. S., Tarby, C., Donnell, A. F., Broekema, M., O’Malley, D. P., Zhang, Y., A M Subbaiah, M., Kumar, B. V., Subramani, L., Wang, B., Li, Y.-X., Sivaprakasam, P., … Gangwar, S. (2024). Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology. ACS Medicinal Chemistry Letters, 15(2), 181–188. https://doi.org/10.1021/acsmedchemlett.3c00455

Chicago

Poudel, Yam B, Liqi He, Matthew Cox, Qian Zhang, Walter L Johnson, Qiang Cong, Heng Cheng, et al. 2024. “Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With APD1 for Use in Immuno-Oncology.” ACS Medicinal Chemistry Letters 15 (2): 181–88. doi:10.1021/acsmedchemlett.3c00455.